{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:36Z","timestamp":1788498996787,"version":"build-2803163510"},"reference-count":23,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Silesia"},{"id":[{"id":"https:\/\/ror.org\/005k7hp45","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Cystic kidney disease is characterized by progressive structural remodeling of renal parenchyma and altered cellular signaling. Inflammatory mediators may contribute to disease biology; however, data on interleukin-15 (IL-15) in pediatric cystic kidney disorders remain limited. The aim of this study was to assess serum and urinary IL-15 concentrations in children with cystic kidney disease and to evaluate their association with renal function. Methods: This study included 47 children with cystic kidney disease and 41 controls without renal cystic disease or other systemic, inflammatory, or immunological disorders. Serum and urinary IL-15 concentrations were measured using an enzyme-linked immunosorbent assay (ELISA). Renal function was assessed using the estimated glomerular filtration rate (eGFR). Statistical analyses included non-parametric comparisons, logistic regression, and receiver operating characteristic (ROC) curve analysis. Results: Children with cystic kidney disease demonstrated significantly elevated serum and urinary IL-15 concentrations compared with controls. IL-15 levels were not associated with eGFR and did not differ between cystic disease subtypes. In logistic regression analysis, IL-15 remained significantly associated with disease status. ROC analysis suggested high diagnostic ability of serum and urinary IL-15. Conclusions: IL-15 concentrations are increased in children with cystic kidney disease independently of current renal function. These findings suggest that IL-15 may reflect early inflammatory or epithelial signaling rather than established functional impairment.<\/jats:p>","DOI":"10.3390\/biomedicines14091982","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:35:29Z","timestamp":1788359729000},"page":"1982","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Interleukin-15 (IL-15) Concentration in Children with Cystic Kidney Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Anna","family":"Bogda\u0142","sequence":"first","affiliation":[{"name":"Department of Pediatrics, District Hospital in Zawiercie, Miodowa Street 14, 42-400 Zawiercie, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Aleksandra","family":"Hop","sequence":"additional","affiliation":[{"name":"Chair and Clinical Department of Pediatrics, Hospital No. 2 in Bytom, ul. Stefana Batorego 15, 41-902 Bytom, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"El\u017cbieta","family":"\u015awi\u0119tochowska","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6925-8409","authenticated-orcid":false,"given":"Artur","family":"Janek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13\/15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Tomasz","family":"Morelewski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13\/15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-005X","authenticated-orcid":false,"given":"Andrzej","family":"Bade\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13\/15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5169-5992","authenticated-orcid":false,"given":"Katarzyna","family":"Otr\u0119bska","sequence":"additional","affiliation":[{"name":"Praski Hospital of the Transfiguration of the Lord, al. Solidarno\u015bci 67, 03-401 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-1983","authenticated-orcid":false,"given":"Maria","family":"Szczepa\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13\/15, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15557\/PiMR.2018.0018","article-title":"Renal cysts in children: A single centre study","volume":"14","author":"Fornalczyk","year":"2018","journal-title":"Pediatr. Med. Rodz."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.urology.2017.07.040","article-title":"Cystic diseases of childhood: A review","volume":"110","author":"Kwatra","year":"2017","journal-title":"Urology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/pr.2013.191","article-title":"Pathophysiology of childhood polycystic kidney diseases: New insights into disease-specific therapy","volume":"75","author":"Sweeney","year":"2013","journal-title":"Pediatr. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00467-010-1656-1","article-title":"Diagnosis and management of childhood polycystic kidney disease","volume":"26","author":"Sweeney","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bakaj, I., and Pocai, A. (2023). Metabolism-based approaches for autosomal dominant polycystic kidney disease. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1126055"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guarnaroli, M., Padoan, F., Fava, C., Benetti, M.G., Brugnara, M., Pietrobelli, A., Piacentini, G., and Pecoraro, L. (2024). The Impact of Autosomal Dominant Polycystic Kidney Disease in Children: A Nephrological, Nutritional, and Psychological Point of View. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081823"},{"key":"ref_7","first-page":"485","article-title":"Zalecenia dotycz\u0105ce post\u0119powania z noworodkiem i niemowl\u0119ciem z prenatalnym podejrzeniem wady wrodzonej uk\u0142adu moczowego [Recommendations for the management of neonates and infants with prenatal suspicion of congenital urinary tract anomaly]","volume":"85","author":"Adamczyk","year":"2009","journal-title":"Pol. Soc. Pediatr. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpurol.2018.09.018","article-title":"Evidence-based treatment of multicystic dysplastic kidney: A systematic review","volume":"14","author":"Chang","year":"2018","journal-title":"J. Pediatr. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"ERA-EDTA Working Group for Inherited Kidney Diseases. Autosomal dominant polycystic kidney disease: The changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bade\u0144ski, A., Bade\u0144ska, M., \u015awi\u0119tochowska, E., Janek, A., Gliwi\u0144ska, A., Morawiec-Knysak, A., and Szczepa\u0144ska, M. (2023). Assessment of Interleukin-15 (IL-15) Concentration in Children with Idiopathic Nephrotic Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24086993"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0000000000000964","article-title":"Interleukin-15 in kidney disease and therapeutics","volume":"33","author":"Hall","year":"2024","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI0214574","article-title":"IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis","volume":"109","author":"Shinozaki","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12979-022-00305-9","article-title":"Excessive IL-15 promotes cytotoxic CD4 + CD28-T cell-mediated renal injury in lupus nephritis","volume":"19","author":"Zhang","year":"2022","journal-title":"Immun. Ageing"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Giron-Michel, J., Azzi, S., Khawam, K., Mortier, E., Caignard, A., Devocelle, A., Ferrini, S., Croce, M., Fran\u00e7ois, H., and Lecru, L. (2012). Interleukin-15 plays a central role in human kidney physiology and cancer through the \u03b3c signaling pathway. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031624"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Devocelle, A., Lecru, L., Ferlicot, S., Bessede, T., Candelier, J.-J., Giron-Michel, J., and Fran\u00e7ois, H. (2021). IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111698"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"De Souza, V.C., Rabilloud, M., Cochat, P., Selistre, L., Hadj-Aissa, A., Kassai, B., Ranchin, B., Berg, U., Herthelius, M., and Dubourg, L. (2012). Schwartz formula: Is one k-coefficient adequate for all children?. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0053439"},{"key":"ref_17","first-page":"690","article-title":"Percentile charts of height, body mass and body mass index in children and adolescents in Poland\u2014Results of the OLAF study","volume":"7","author":"Palczewska","year":"2010","journal-title":"Stand. Med. Pediatr."},{"key":"ref_18","first-page":"100","article-title":"Distribution of blood pressure in school-aged children and adolescents reference population","volume":"7","author":"Litwin","year":"2010","journal-title":"Stand. Med. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Song, X., Pickel, L., Sung, H.K., Scholey, J., and Pei, Y. (2024). Reprogramming of Energy Metabolism in Human PKD1 Polycystic Kidney Disease: A Systems Biology Analysis. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202405.0678.v1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.34067\/KID.0000000000000525","article-title":"Inflammatory Cytokine Levels in Patients with Autosomal Dominant Polycystic Kidney Disease","volume":"5","author":"Arjune","year":"2024","journal-title":"Kidney360"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2025.01.022","article-title":"Polycystic Kidney Disease in Children: The Current Status and the Next Horizon","volume":"86","author":"Cadnapaphornchai","year":"2025","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ene, C.D., Nicolae, I., and C\u0103pu\u0219\u0103, C. (2024). Abnormalities of IL-12 Family Cytokine Pathways in Autosomal Dominant Polycystic Kidney Disease Progression. Medicina, 60.","DOI":"10.3390\/medicina60121971"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ekir.2024.01.010","article-title":"Protective Role of the Podocyte IL-15 \/ STAT5 Pathway in Focal Segmental Glomerulosclerosis","volume":"9","author":"Niasse","year":"2024","journal-title":"Kidney Int. Rep."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/9\/1982\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:19Z","timestamp":1788496039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/9\/1982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["biomedicines14091982"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14091982","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}